SLC34A1 and hyperphosphatemia: As well as the known acute effects of OSP (hyperphosphatemia, hypocalcemia and APN), the effects of OSP on serum PTH and FGF-23 levels and on the expression of NaPi co-transporter proteins in the kidney (NaPi-2a) were investigated.